Cellular and molecular mechanisms in kidney fibrosis

Fibrosis is a characteristic feature of all forms of chronic kidney disease. Deposition of pathological matrix in the interstitial space and within the walls of glomerular capillaries as well as the cellular processes resulting in this deposition are increasingly recognized as important factors amplifying kidney injury and accelerating nephron demise. Recent insights into the cellular and molecular mechanisms of fibrogenesis herald the promise of new therapies to slow kidney disease progression. This review focuses on new findings that enhance understanding of cellular and molecular mechanisms of fibrosis, the characteristics of myofibroblasts, their progenitors, and molecular pathways regulating both…

• AH
  American Heart Association

  Award: 12040023
• EL
  Eli Lilly and Company
• B
  Biogen

  Awards: DK094768, DK093493
• UO
  University of Washington
• NI
  National Institutes of Health

  Awards: TR000504, DK094768, DK093493
• UO
  University of Texas Health Science Center at San Antonio